ENTITY

Metsera (MTSR US)

13
Analysis
Health Care • United States
Clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases.
more
Exchange Announcement • 14 Nov 2025 05:53

Current Report (Form 8-K | Period ending 2025-11-12)

Exchange Announcement • 13 Nov 2025 05:05

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Exchange Announcement • 10 Nov 2025 20:52

Current Report (Form 8-K | Period ending 2025-11-07)

Exchange Announcement • 04 Nov 2025 23:47

Current Report (Form 8-K | Period ending 2025-11-03)

Exchange Announcement • 04 Nov 2025 01:17

Current Report (Form 8-K | Period ending 2025-11-03)

x